gene_symbol
UNKNOWN
binding_type
antigen recognition
cytotoxicity
YES
cytotoxicity_type
INDIRECT
cytotoxicity_mechanism
DC vaccine primes tumor-specific CD8+ T cells that recognize neoantigen peptides presented on HLA-I and kill target cells via perforin/granzyme-mediated cytolysis and Fas–FasL apoptosis.
enzyme_product
Off
epitope
On
variant
On
isoform
Off
hla_specific
On
gated
Off
other_modifier
Peptide–MHC I complexes recognized by CD8+ T cells
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT06043232
disease_id_num_tar_ref
2555
drug_id_num_tar_ref
6825